Preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography imaging in head and neck cancer: Does it really improve initial N staging?

Acta Oto-Laryngologica

Volumn 130, Issue 12, 2010, Pages 1421-1424

  Richard, Celine ^a   Prevot, Nathalie ^a   Timoshenko, Andrei P ^a   Dumollard, Jean Marc ^a   Dubois, Francis ^a   Martin, Christian ^a   Prades, Jean Michel ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Histopathological results; Neck dissection

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; MALE; METASTASIS; NECK DISSECTION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78649273999     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.3109/00016489.2010.502183     Document Type: Article

References (10)

1. Zanation AM, Sutton DK, Couch ME, Weissler MC, Shokley WW, Shores CG. Use, accuracy and implications for patient management of [18F]-2- Fluorodeoxyglucosepositron emission/computerized tomography for head and neck tumors. Laryngoscope 2005;115:1186-90.
2. Hannah A, Scott AM, Tochon-Danguy H, Chan JG, Akhurst T, Berlangieri S, et al. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg 2002;236:208-17.
3. Quon A, Fischbein NJ, McDougall IR, Le QT, Loo BW Jr, Pinto H, et al. Clinical role of 18-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med 2007;48(Suppl 1): 58S-67S.
4. Ha PK, Hdeib A, Goldenberg D, Jacene H, Patel P, Koch W, et al. The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006;132:12-16.
5. Yamazaki Y, Saitoh M, Notani K, Tei K, Totsuka Y, Takinami S, et al. Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer. Ann Nucl Med 2008;22:177-84.
6. Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 2005;46:1136-43.
7. Jeong HS, Baek CH, Son YI, Ki Chung M, Kyung Lee D, Young Choi J. Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma. Head Neck 2007;29:203-10.
8. Menda Y, GrahamMM. Update on 18 F-fluorodeoxyglucose/ positron emission tomography and positron emission tomography/computed tomography imaging squamous head and neck cancers. Semin Nucl Med 2005;35:214-19.
9. Schöder H, Carlson DL, Kraus DH, Stambuk HE, GönenM, Erdi YE, et al. 18F-FDG PET/CT for detecting model metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 2006;47:755-62.
10. Gourin CG, Boyce BJ, Williams HT, Herdman AV, Bilodeau PA, Coleman TA. Revisiting the role of positronemission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer. Laryngoscope 2009; 119:2150-5.